Bokus
Katherine Seley-Radtke - Annual Reports in Medicinal Chemistry, Inbunden

Inbunden, Engelska, 2026

Annual Reports in Medicinal Chemistry

New Approaches in Conjugate Drug Design: Part 1

Av Katherine Seley-Radtke

Del 67 i serien Annual Reports in Medicinal Chemistry

2468 kr

Kommande

Fler format och utgåvor

Beskrivning
New Approaches in Conjugate Drug Design: Part 1, published as Volume 67 of the serial Annual Reports in Medicinal Chemistry, provides a comprehensive overview of current strategies in the design and application of drug conjugates. Chapters cover small molecule drug conjugates, antibody-to-small molecule carrier approaches, antibiotic-derived and terpene-derived antimicrobial conjugates, aptamer-RNA conjugates, and phenolic and metal natural product conjugates. Applications span anticancer, antiviral, antifungal, and theranostic therapies, including photoactivatable therapy and emerging approaches in quantum oncology. The volume serves as a reference on design principles, therapeutic applications, and clinical progress in conjugate-based drug discovery.

  • Surveys design principles, therapeutic applications, and clinical progress of small molecule drug conjugates
  • Covers diverse conjugate classes, including antibiotic-derived, terpene-derived, aptamer-RNA, phenolic, and metal natural product conjugates
  • Addresses applications across anticancer, antiviral, antifungal, and antimicrobial drug discovery
  • Includes emerging approaches such as theranostic conjugates, photoactivatable therapy, and quantum oncology
  • Features contributions from an international group of expert authors
Produktinformation
Utforska kategorier
Mer om författaren

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach tonucleoside, nucleotide and heterocyclic drug discovery and development with therapeuticemphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currentlyused drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served asthe Program Director for UMBC’s Chemistry-Biology Interface graduate training programfunded by NIH since 2007. This program promotes hands on cross disciplinary research foralmost 50 PhD students from four departments at UMBC and UMB. She is currently theImmediate Past President and Secretary-Elect for the International Society of Nucleosides,Nucleotides and Nucleic Acids and a Board member of the International Society for AntiviralResearch. Prof. Seley-Radtke also serves as a standing member for several NIH study sectionsand is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy,Molecules – Chemical Biology, and Current Protocols in Chemical Biology.

Recensioner i media

Select Guide Rating

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.